Related Experiment Video
Updated: Nov 6, 2025

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
LDL cholesterol and atherosclerosis: The evidence
Carlos Guijarro1, Juan Cosín-Sales2
1Unidad de Medicina Interna, Hospital Universitario Fundación Alcorcón, Madrid, España; Departamento de Especialidades Médicas y Salud Pública, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Madrid, España.
Insights
High LDL cholesterol is a primary cause of atherosclerosis, a major global killer. Recent genetic and clinical studies confirm that lowering LDL cholesterol is essential for preventing cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Metabolic Disease Research
- Genetic Epidemiology
Background:
- Atherosclerosis, a leading cause of global mortality, has long been associated with lipid levels.
- Despite extensive evidence, the role of hypercholesterolemia in atherosclerosis development has faced recent scrutiny.
- Atherosclerotic cardiovascular disease (ASCVD) remains a critical public health concern worldwide.
Purpose of the Study:
- To review recent genetic and clinical evidence on the role of LDL cholesterol in atherosclerosis.
- To reaffirm the etiological significance of LDL cholesterol in atherosclerotic development.
- To emphasize the importance of LDL cholesterol lowering in managing cardiovascular complications.
Main Methods:
- Review of recent Mendelian randomization genetic studies.
- Analysis of randomized clinical trials focused on LDL cholesterol reduction.
- Synthesis of experimental, epidemiological, and clinical evidence.
Main Results:
- Recent genetic studies unequivocally support the causal role of LDL cholesterol in atherosclerosis.
- Randomized clinical trials demonstrate significant cardiovascular risk reduction with LDL cholesterol lowering.
- Evidence consistently validates the lipid theory of atherosclerosis.
Conclusions:
- LDL cholesterol is definitively established as a key etiological factor in atherosclerosis.
- Lowering LDL cholesterol is the cornerstone of effective lipid-lowering therapy for ASCVD.
- Therapeutic strategies targeting LDL cholesterol are crucial for reducing atherosclerotic cardiovascular complications.
Abstract:
The lipid theory of atherosclerosis dates back more than a century. Despite this, some authors have questioned the relevance of hypercholesterolaemia in its development. Multiple experimental, epidemiological, and clinical evidence underpins this association. Atherosclerotic cardiovascular disease remains as the major cause of mortality in the world. Recent genetic studies of Mendelian randomisation and randomised clinical trials aimed at LDL cholesterol reduction, are summarised in this article. They, unequivocally ratify the aetiological role of LDL cholesterol in the development of atherosclerosis. Thus, LDL cholesterol lowering is the cornerstone of lipid lowering therapy for the reduction of cardiovascular complications of atherosclerosis.
More Related Videos
Related Concept Videos
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Inflammation
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology

